Abivax Not Rushing Deals as It Awaits Crucial Trial Results
French biotech company Abivax is choosing patience over urgency. Despite growing takeover speculation, the company is holding off on major
Big Pharma Races to Snap Up Biotech Assets as $170 Billion Patent Cliff Nears
Global pharmaceutical giants are accelerating efforts to acquire biotech companies and late-stage drug assets as the industry braces for a
Eli Lilly Makes History: How a Weight-Loss Shot Pushed a Drugmaker to the Trillion-Dollar Club
For the first time in history, a health-care company has stepped into a territory once reserved almost entirely for the
Novo Nordisk Faces Turbulent Board Shakeup as Weight-Loss Drug Market Pressures Intensify
Novo Nordisk Shareholders Approve Major Board Overhaul Novo Nordisk has entered a decisive new chapter after shareholders approved a sweeping